VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,227,626 | -31.4% | 22,748,880 | 0.0% | 0.95% | -28.5% |
Q2 2023 | $70,294,039 | -42.6% | 22,748,880 | 0.0% | 1.33% | -52.1% |
Q1 2023 | $122,388,974 | -19.1% | 22,748,880 | 0.0% | 2.77% | -9.7% |
Q4 2022 | $151,280,052 | +241.8% | 22,748,880 | +104.6% | 3.07% | +225.0% |
Q3 2022 | $44,261,000 | -19.9% | 11,120,973 | 0.0% | 0.94% | -36.0% |
Q2 2022 | $55,271,000 | -17.7% | 11,120,973 | 0.0% | 1.47% | +0.5% |
Q1 2022 | $67,171,000 | -48.0% | 11,120,973 | 0.0% | 1.47% | -35.6% |
Q4 2021 | $129,226,000 | -25.9% | 11,120,973 | 0.0% | 2.28% | -5.7% |
Q3 2021 | $174,377,000 | -15.9% | 11,120,973 | 0.0% | 2.42% | -27.4% |
Q2 2021 | $207,406,000 | -56.7% | 11,120,973 | 0.0% | 3.33% | -53.9% |
Q1 2021 | $479,314,000 | – | 11,120,973 | – | 7.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,692,429 | $124,814,000 | 31.41% |
Trustees of Columbia University in the City of New York | 183,821 | $3,428,000 | 5.06% |
RA Capital Management | 11,120,973 | $207,406,000 | 3.33% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20,042,000 | 2.05% |
Sarissa Capital Management LP | 707,010 | $13,186,000 | 1.05% |
SECTORAL ASSET MANAGEMENT INC | 405,324 | $7,559,000 | 0.61% |
Woodline Partners LP | 1,146,494 | $21,382,000 | 0.40% |
Artal Group S.A. | 550,000 | $10,258,000 | 0.21% |
NEXPOINT ASSET MANAGEMENT, L.P. | 50,000 | $933,000 | 0.20% |
Orbimed Advisors | 833,333 | $15,542,000 | 0.16% |